A brief introductory video explaining Micropore's unique membrane-based system
Our Unique Technology
Back to Latest News
With lipid nanoparticles moving beyond mRNA vaccines, biopharma are racing against the clock to exploit clinical utility to deliver more complex payloads, while optimising scalability and product quality.
Micropore will be again participating in this 3-day summit 17-19 October in Amsterdam, together with 100+ senior leaders, sharing exclusive data to help maximise this non-viral delivery system's potential.
The 2nd Lipid Nanoparticle Development Europe Summit is committed to equipping participants with actionable takeaways across end-to-end characterisation, biodistribution, formulation and scale up to supercharge LNP pipeline development with therapeutic promise for patients.
At Micropore we enjoy working in partnership with our clients to solve formulation challenges and deliver the highest performing, most sustainable, most cost-effective formulated delivery systems.
Keep up to date with innovations at Micropore. Sign up today to stay informed with innovations at Micropore and automatically receive the Micropore newsletter and webinar invites.